ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 126 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,353 | -74.2% | 93,729 | 0.0% | 0.00% | – |
| Q2 2023 | $47,802 | -19.0% | 93,729 | 0.0% | 0.00% | – |
| Q1 2023 | $59,049 | -2.9% | 93,729 | 0.0% | 0.00% | – |
| Q4 2022 | $60,839 | -62.2% | 93,729 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $161,000 | +38.8% | 93,729 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $116,000 | -66.6% | 93,729 | +57.3% | 0.00% | -50.0% |
| Q2 2019 | $347,000 | +1.8% | 59,580 | -32.7% | 0.00% | 0.0% |
| Q1 2019 | $341,000 | +105.4% | 88,580 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $166,000 | -40.5% | 88,580 | +1.7% | 0.00% | -50.0% |
| Q3 2018 | $279,000 | +6.1% | 87,080 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $263,000 | +124.8% | 87,080 | +520.9% | 0.00% | +100.0% |
| Q4 2015 | $117,000 | – | 14,024 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |